CSE PREV
LAST 0.025
CHANGE 0.000
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.025
CHANGE: 0.000
OTC: PRVCF
FSE: 18H
Download as PDF  

PreveCeutical's Chief Research Officer, Dr. Harry Parekh joined Steve Darling from Proactive Investors to talk about the companies progress in the development of their Sol-gel Program.

PreveCeutical's Chief Research Officer, Dr. Harry Parekh joined Steve Darling from Proactive Investors to talk about the companies progress in the development of their Sol-gel Program.

Sign up for the latest news and updates